Tempest Therapeutics Statistics

Total Valuation

TPST has a market cap or net worth of $24.67 million. The enterprise value is $13.50 million.

Market Cap	24.67M
Enterprise Value	13.50M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPST has 3.68 million shares outstanding. The number of shares has increased by 91.15% in one year.

Current Share Class	3.68M
Shares Outstanding	3.68M
Shares Change (YoY)	+91.15%
Shares Change (QoQ)	+9.01%
Owned by Insiders (%)	0.18%
Owned by Institutions (%)	5.19%
Float	3.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.88
P/TBV Ratio	1.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 1.18.

Current Ratio	1.70
Quick Ratio	1.63
Debt / Equity	1.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-40.57

Financial Efficiency

Return on equity (ROE) is -282.07% and return on invested capital (ROIC) is -86.20%.

Return on Equity (ROE)	-282.07%
Return on Assets (ROA)	-73.47%
Return on Invested Capital (ROIC)	-86.20%
Return on Capital Employed (ROCE)	-236.94%
Revenue Per Employee	n/a
Profits Per Employee	-$1.87M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.48% in the last 52 weeks. The beta is -2.22, so TPST's price volatility has been lower than the market average.

Beta (5Y)	-2.22
52-Week Price Change	-84.48%
50-Day Moving Average	7.51
200-Day Moving Average	11.96
Relative Strength Index (RSI)	48.62
Average Volume (20 Days)	41,426

Short Selling Information

The latest short interest is 127,899, so 3.47% of the outstanding shares have been sold short.

Short Interest	127,899
Short Previous Month	109,252
Short % of Shares Out	3.47%
Short % of Float	3.97%
Short Ratio (days to cover)	2.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.99M
Pretax Income	-31.75M
Net Income	-44.80M
EBITDA	-44.62M
EBIT	-44.99M
Earnings Per Share (EPS)	-$17.38

Full Income Statement

Balance Sheet

The company has $21.51 million in cash and $13.11 million in debt, giving a net cash position of $8.41 million or $2.28 per share.

Cash & Cash Equivalents	21.51M
Total Debt	13.11M
Net Cash	8.41M
Net Cash Per Share	$2.28
Equity (Book Value)	11.13M
Book Value Per Share	3.16
Working Capital	9.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.88 million and capital expenditures -$267,000, giving a free cash flow of -$34.14 million.

Operating Cash Flow	-33.88M
Capital Expenditures	-267,000
Free Cash Flow	-34.14M
FCF Per Share	-$9.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-91.15%
Shareholder Yield	-91.15%
Earnings Yield	-204.46%
FCF Yield	-155.83%

Analyst Forecast

The average price target for TPST is $30.00, which is 347.76% higher than the current price. The consensus rating is "Hold".

Price Target	$30.00
Price Target Difference	347.76%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.59%

Stock Forecasts

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 0.0769231:1.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	0.0769231:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1